Parkinson's disease (PO) is a progressive neurodegenerative disorder affecting muscle controls. There is no drug avidlable to date that can hamper disease progression, which is characterised by further neurodegeneration. This paper reviews a set of current treatments and assesses the clinical usefulness and the limitation of the drugs.
Parkinson's disease (PO) is a progressive neurodegenerative disorder affecting muscle controls. There is no drug avidlable to date that can hamper disease progression, which is characterised by further neurodegeneration. This paper reviews a set of current treatments and assesses the clinical usefulness and the limitation of the drugs.
Parkinson's disease (PO) is a progressive neurodegenerative disorder affecting muscle controls. There is no drug avidlable to date that can hamper disease progression, which is characterised by further neurodegeneration. This paper reviews a set of current treatments and assesses the clinical usefulness and the limitation of the drugs.